Indeed, Shi et al demonstrated that the physical interaction between EZH2 and ER stimulated the gene transactivation of estrogen and Wnt pathways, hence phenotypically promoting the breast cancer cell cycle progression (82). The gene discussed is EZH2; the disease is breast carcinoma.